new glp 1 agonist Molecules and Emerging Indications for GLP-1 Medicines Color coding GLP-1 Agonists in Cardiovascular Diseases:

Description

What is already known on this topic Preclinical studies suggest glucagon-like peptide-1 (GLP-1) receptor agonists act on the mesolimbic reward pathways and reduce drug reinforcement in animal models of alcohol, nicotine, cocaine, and opioid use disorders Observational studies in humans link GLP-1 receptor agonist use to lower risk of incident and recurrent alcohol, tobacco, and cannabis use disorders, but evidence for other substances is lacking Large studies evaluating GLP-1 receptor agonists for preventing substance use disorders (SUDs) or improving hard clinical outcomes in people with established SUDs are lacking What this study adds GLP-1 receptor agonists were associated with lower risks of incident alcohol, cannabis, cocaine, nicotine, opioid, and other SUDs, suggesting potential preventive effects across a broad range of substances In participants with pre-existing SUDs, GLP-1 receptor agonists were associated with reduced risks of SUD related emergency department visits, hospital admissions, and mortality, and drug overdoses and suicidal behaviours Ethics statements Ethical approval This study was approved by the institutional review board of the VA St Louis Health Care System, which granted a waiver of informed consent (protocol No 1606333)

Ozempic does not have a dedicated self-pay pricing program

To address the issue they performed transfusion experiments with dogs where they connected the pancreatic vein of a donor dog to the jugular vein of a recipient dog and then injected secretin extracts

[DOI] [PMC free article] [PubMed] [Google Scholar] 48.Bluher M, Rosenstock J, Hoefler J, Manuel R, Hennige AM

Side effects of Ozempic alternatives Because most Ozempic alternatives are GLP-1 receptor agonists that work similarly to Ozempic, they share many of the same side effects